IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#4361
Positioning
Market Dominance
Mining
Precious Metals
$0
Dennis L. Higgs
Austin Gold Corp. focuses on the exploration of mineral property interests in Nevada. Its principal property the Kelly Creek Project comprises options and leases covering 136.8 km2. The company's other projects include the Fourmile Basin Project that comprises 323 unpatented lode mining claims.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$VALE Vale S.A. | 75 | 88 | 93 | 67 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$SU SUNCOR ENERGY INC | 74 | 87 | 90 | 53 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$TRX TRX GOLD Corp | 72 | 83 | 77 | 96 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$ORLA Orla Mining Ltd. | 72 | 94 | 83 | 78 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$KGC KINROSS GOLD CORP | 71 | 83 | 89 | 79 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$AEM AGNICO EAGLE MINES LTD | 71 | 80 | 80 | 71 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$RIO RIO TINTO PLC | 70 | 76 | 84 | 64 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$IAG IAMGOLD CORP | 70 | 71 | 82 | 89 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$NGD New Gold Inc. /FI | 70 | 76 | 67 | 92 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$PDS PRECISION DRILLING Corp | 70 | 77 | 90 | 65 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$AUST Austin Gold Corp. | 32 | 14 | 6 | 47 | - | - | -132.6% | -129.5% | - | - | - | - | - | 0.0x | $0 | ||
| SECTOR BENCH | - | - | - | - | - | 13.7x | 5.2x | 4.3% | 3.9% | 45.8% | 7.6% | 5.8% | 0.1% | 0.0% | 0.3x | - | REF |
Austin Gold Corp. (AUST) receives a "Avoid" rating with a composite score of 32.2/100. It ranks #4361 out of 7,333 stocks in our coverage universe and carries a 1-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
In-line with peers — no strong momentum signal
Expensive relative to fundamentals — limited margin of safety
Weak fundamentals — higher risk of value trap
High volatility — wider range of outcomes increases timing risk
Moderate investment profile
Below-average composite — caution warranted
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Mining sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for AUST.
View All Ratings| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 14 | 2 | +12ALPHA |
| MOMENTUM | 47 | 47 | 0NEUTRAL |
| VALUATION | 6 | 2 | +4NEUTRAL |
| INVESTMENT | 56 | 89 | -33DRAG |
| STABILITY | 21 | 10 | +11ALPHA |
| SHORT INT | 49 | 52 | -3NEUTRAL |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROE proxy -132.6% (sector 4.3%)
GM N/A vs sector 46%, OM N/A vs sector 8%
Capital turnover N/A
Rev growth N/A, 3yr history
Interest coverage N/A
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
We rate Austin Gold Corp. (AUST) as Avoid with a composite score of 32.2/100 at a current price of $2.03. The stock falls in the bottom quintile, and the multi-factor weakness suggests a high probability of continued underperformance.
Austin Gold Corp. holds a top-quartile position (#0 of 50) within the Mining sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 32.2/100 places it at rank #4361 in our full universe.
No Moat
High
Poor
Fair Value
Stable competitive position in a defensive sector.
Below-average quality raises earnings sustainability concerns.
Vulnerability to macroeconomic shocks and interest rate volatility.
Austin Gold Corp. represents a avoid based on multi-factor quantitative performance.
Our quantitative model flags Austin Gold Corp. with an Avoid rating, assigning a composite score of 32.2/100 and 1 out of 5 stars. Ranked #4361 of 7,333 stocks, AUST falls in the bottom tier across key factors. Historically, stocks with this profile have faced elevated risk of underperformance and capital loss.
Austin Gold Corp. registers a weak quality score of just 14/100, indicating significant profitability challenges. The company reports a return on equity of -132.6% (sector avg: 4.3%). Low quality scores are often associated with businesses in turnaround mode, early-stage growth, or structurally challenged industries.
AUST registers a value score of just 6/100, suggesting the stock trades at a significant premium to its fundamental metrics. Key valuation metrics include a P/B ratio of 2.79x. High-premium valuations like this require strong future execution to avoid multiple compression, and downside risk is elevated if growth disappoints.
With an investment score of 56/100, AUST exhibits moderate growth-oriented spending. Key growth metrics include a return on assets of -129.5% (sector: 3.9%). The company appears to be balancing growth investments with capital returns, though the pace of investment may not be enough to accelerate top-line growth meaningfully.
AUST is currently showing below-average momentum at 47/100, which may indicate weakening institutional interest or negative sentiment shifts. Revenue growth data is not currently available, while a beta of 0.95 reflects its sensitivity to broader market moves. Investors should note that declining momentum can precede further price weakness, though contrarian opportunities sometimes emerge at these levels.
Austin Gold Corp. registers a low stability score of 21/100, indicating high volatility and potentially stressed financial conditions. Key stability metrics include a beta of 0.95 and a debt-to-equity ratio of 0.00x (sector avg: 0.3x). Stocks at this level carry elevated capital loss risk and may be unsuitable for conservative portfolios without careful risk management.
The short interest score of 49/100 for AUST suggests somewhat elevated bearish positioning by institutional traders. Specific risk factors include micro-cap liquidity risk. With a $0 market cap (micro-cap), Austin Gold Corp. may experience above-average volatility. Investors should consider whether the short thesis has merit or if it creates a potential short-squeeze opportunity.
Austin Gold Corp. is a micro-cap company in the Mining sector, ranked #0 of 50 in its sector (100th percentile) and #4361 of 7,333 overall (41st percentile). Key comparisons include ROE of -132.6% trailing the 4.3% sector median. This top-quartile standing reflects exceptional competitive strength relative to Mining peers.
While AUST currently exhibits a AVOID profile, superior opportunities exist within the MINING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Mining Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Value (6) would have the largest impact on the composite score.
ROE 3185% BELOW SECTOR MEDIAN
Debt/Equity 100% BELOW SECTOR MEDIAN (FAVORABLE)
Above 50MA
37.18%
Net New Highs
+51081

The price of gold reached all-time high of over $2,200 per ounce this week, reacting positively to the indications emerging from the latest Federal Open Market Committee (FOMC) meeting in which policymakers reiterated their intentions to cut interest rates three times in the current year. The precious metal already surged by 6% this month, marking its fourth positive week out of the last five, sparking a revival in gold mining stocks. In a recent note from Bank of America published this week, analysts reiterated gold remained one of the favored trades for 2024, citing three key drivers: its hedge status against global stocks, central banks’ accumulation of gold at record levels and the potential for increased investor participation in ETF purchases. Bank ...Full story available on Benzinga.com

Gainers Getaround, Inc. (NYSE: GETR) shares surged 112% to $0.7020 in pre-market trading. Getaround acquired substantially all assets of HyreCar for an aggregate purchase price of $9.45 million. Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares rose 35.2% to $2.61 in pre-market trading after the company highlighted recent corporate progress, and reported financial results for the first quarter. Blue Bird Corporation (NASDAQ: BLBD) shares gained 30% to $25.16 in pre-market trading after the company reported better-than-expected Q2 results. Rubicon Technologies, Inc. (NYSE: RBT) shares rose 19.5% to $0.5340 in pre-market trading after dropping around 15% on Thursday. Momentus Inc. (NASDAQ: MNTS) shares gained 18.5% to $0.4979 in pre-market trading following Q1 results. Babylon Holdings Limited (NYSE: BBLN) shares climbed 16% to $1.38 in pre-market trading after dropping 42% on Thursday. Babylon recently reported mixed Q1 financial results. The company also announced it secured financing and plans to implement a ...

Gainers Provention Bio, Inc. (NASDAQ: PRVB) shares jumped 250.8% to $23.50 after Sanofi announced it will acquire the company for $25 per share in cash. Hycroft Mining Holding Corporation (NASDAQ: HYMC) surged 41.6% to $0.4390. Calliditas Therapeutics AB (NASDAQ: CALT) shares gained 33.7% to $22.73 after the company announced the primary endpoint was successfully met in the Phase 2 NefIgArd trial evaluating Nefecon in IgA nephropathy. Clearmind Medicine Inc. (NASDAQ: CMND) gained 31.7% to $4.53. Cipher Mining Inc. (NASDAQ: CIFR) rose 30.2% to $1.7195. EUDA Health Holdings Limited (NASDAQ: EUDA) gained 30% to $2.62. ZIM Integrated Shipping Services Ltd. (NYSE: ZIM) surged 23.7% to $24.20 after the company reported a fourth-quarter FY22 sales decline of 37% year-on-year to $2.19 billion, beating the consensus of $2.11 billion. Austin Gold Corp. (NYSE: AUST) rose 22.2% to $1.10 Iris Energy Limited (NASDAQ: IREN) rose 22% to $3.16. Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) gained 20% to $0.5530 after the company announced the primary and secondary endpoints were met in the Phase 2a study of AR-501 in cystic fibrosis patients. Hut 8 Mining Corp. (NASDAQ: HUT) gained 20% to $1.5200. Hut 8 Mining announced expiration of Hart-Scott-Rodino Antitrust Improvements Act regarding proposed combination with U.S. Data Mining Group. Stronghold Digital Mining, Inc. (NASDAQ: SDIG) jumped 19.6% to $0.5401. Latch, Inc. (NASDAQ: LTCH) surged 17.7% to $0.6029. Illumina, Inc. (NASDAQ: ILMN) rose 17.7% to $228.41 following a media report stating Carl Icahn is preparing to become an activist investor in the company. Seagen Inc. (NASDAQ: SGEN) gained 16.8% to $201.65 after Pfizer announced it would acquire the company for $229 per share in cash. Zynex, Inc. (NASDAQ: ZYXI) jumped 15.7% to $11.03 following upbeat quarterly earnings. Harmony Gold Mining Company Limited (NYSE: HMY) gained 15% to $3.6350. Shares of gold companies traded higher amid a decline in the US dollar. Kinnate ...

Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) shares climbed 106.3% to close at $9.15. Avenue Therapeutics recently received the official meeting minutes from the FDA regarding a meeting conducted for IV Tramadol in combination with other opioid analgesics to manage moderate-to-moderately severe pain. Concurrently, Avenue Therapeutics announced that it would effect a 1-for-15 reverse stock split. Scienjoy Holding Corporation (NASDAQ: SJ) climbed 47.9% to close at $2.47 after declining 44% on Monday. Sonendo, Inc. (NASDAQ: SONX) gained 42.7% to close at $1.67. Sonendo recently announced a private placement of common stock and pre-funded warrants, resulting in gross proceeds of $63 million led by a consortium of new and existing investors. X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) gained 40.2% to close at $1.25 after the company announced data from its Phase 1b trial evaluating mavorixafor in chronic neutropenia. Antelope Enterprise Holdings Limited (NASDAQ: AEHL) rose 37.5% to settle at $0.9320. Grove Collaborative Holdings, Inc. (NYSE: GROV) shares surged 35.5% to close at $4.01. Grove Collaborative continued retail expansion with entry into thousands of more stores. InMed Pharmaceuticals Inc. (NASDAQ: INM) climbed 31.3% to close at $6.71. InMed recently reported a FY22 net loss of $33.17 per share. AN2 Therapeutics, Inc. (NASDAQ: ANTX) gained 31.1% to close at $15.50. FingerMotion, Inc. (NASDAQ: FNGR) climbed 30.3% to close at $1.0592 after rising around 20% on Monday. Intelligent Living Application Group Inc. (NASDAQ: ILAG) gained 28.4% to close at $2.62 after gaining over 11% on Monday. Harrow Health, Inc. (NASDAQ: HROW) gained 27.9% to close at $9.73 after the company announced the FDA has approved IHEEZO 3% for ocular surface anesthesia. Presto Automation, Inc. (NASDAQ: PRST) jumped 24% to close at $2.69. Equillium, Inc. (NASDAQ: EQ) climbed 22.8% to close at $2.37. Equillium announced interim results from the Type B portion of the EQUALISE study evaluating itolizumab in patients with lupus nephritis (LN). Lion Group Holding Ltd. (NASDAQ: LGHL) rose 22.8% to close at $2.10. PaxMedica, Inc. (NASDAQ: PXMD) gained 18.4% to close at $2.57 as the company issued a corporate update after IPO. The company named Stephen D. Sheldon as CFO. Latch, Inc. (NASDAQ: LTCH) rose 18.1% to close at $1.01. Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) gained 18% to close at $1.14. Bellerophon announced FDA acceptance of change to ongoing Phase 3 REBUILD study of INOpulse for the treatment of fibrotic interstitial lung disease. Metacrine, Inc. (NASDAQ: MTCR) rose 17.7% to ...

AUST, GIL and FMAO have been added to the Zacks Rank #5 (Strong Sell) List on September 25, 2023.